We further examined SELENBP1 mRNA levels in The Cancer Genome Atlas bladder cancer (TCGA-BLCA) cohort, including 406 patients with SELENBP1 expression data, in which 19 of patients have SELENBP1 expression data of primary tumor and matched normal bladder tissues. Here, SELENBP1 is linked to neoplasm.